person

Elisabeth C.

Country
France
Department
oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
143
Sites with multiple studies

Has run more than one trial at 143 of 333 partner sites.

Specializations

Breast Cancer Specialization

This investigator focuses on advanced therapeutic approaches for HER2-positive and HER2-negative breast cancer, with particular attention to treatment strategies in specific patient populations. Their research encompasses hormone receptor-positive disease and innovative combination therapies.

  • Early-stage HER2-positive breast cancer treatment
  • Hormone receptor-positive metastatic disease
  • Age-specific treatment approaches in elderly patients

The investigator explores targeted therapies including trastuzumab emtansine and abemaciclib combinations.

Gastrointestinal Oncology

Research activities include innovative approaches in colon cancer treatment, with specific focus on early-stage disease management. The investigator explores circulating tumor DNA applications in treatment decision-making.

  • Stage II colon cancer therapy
  • Adjuvant treatment strategies
  • Molecular monitoring approaches

Their work incorporates biomarker-driven treatment selection in gastrointestinal oncology.

Precision Oncology

The investigator specializes in molecular-targeted therapies across multiple tumor types, including research on FGFR alterations in solid tumors and MMR-deficient cancers.

  • Targeted therapy for FGFR-altered tumors
  • Endometrial cancer treatment
  • Genomic profiling applications

Their research extends to novel applications of immunotherapy and precision medicine approaches in various cancer types.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.